We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE: CVRS) to a subsidiary of Siemens Healthineers AG (“Siemens”). Under the terms of the deal, a wholly-owned subsidiary of Siemens Healthineers AG, a German stock listed company, will acquire all issued and outstanding shares of common stock of Corindus for $4.28 per share in cash.
The Corindus merger investigation concerns whether the Board of Corindus breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Siemens is underpaying for Corindus shares, thus unlawfully harming Corindus shareholders
To receive more information, please fill out the form.